Mobile

A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated...

Update Il y a 5 ans
Reference: EUCTR2007-002872-32

A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Safety Objective To compare the safety of a single intramuscular (IM) dose of the cell-derived influenza subunit vaccine (Optaflu®) with that of the egg-derived influenza subunit vaccine (Agrippal®) in adult and elderly subjects with and without underlying conditions.

Inclusion criteria

  • No medical condition, healthy subjects

Links